Abstract:BackgroundCathepsin B (catB) is a promising target for anti-cancer drug design due to its implication in several steps of tumorigenesis. catB activity and inhibition are pH-dependent, making it difficult to identify efficient inhibitor candidates for clinical trials. In addition it is known that heparin binding stabilizes the enzyme in alkaline conditions. However, the molecular mechanism of stabilization is not well understood, indicating the need for more detailed structural and dynamic studies in order to clarify the influence of pH and heparin binding on catB stability.ResultsOur pKa calculations of catB titratable residues revealed distinct protonation states under different pH conditions for six key residues, of which four lie in the crucial interdomain interface. This implies changes in the overall charge distribution at the catB surface, as revealed by calculation of the electrostatic potential. We identified two basic surface regions as possible heparin binding sites, which were confirmed by docking calculations. Molecular dynamics (MD) of both apo catB and catB-heparin complexes were performed using protonation states for catB residues corresponding to the relevant acidic or alkaline conditions. The MD of apo catB at pH 5.5 was very stable, and presented the highest number and occupancy of hydrogen bonds within the inter-domain interface. In contrast, under alkaline conditions the enzyme's overall flexibility was increased: interactions between active site residues were lost, helical content decreased, and domain separation was observed as well as high-amplitude motions of the occluding loop – a main target of drug design studies. Essential dynamics analysis revealed that heparin binding modulates large amplitude motions promoting rearrangement of contacts between catB domains, thus favoring the maintenance of helical content as well as active site stability.ConclusionsThe results of our study contribute to unraveling the molecular events involved in catB inactivation in alkaline pH, highlighting the fact that protonation changes of few residues can alter the overall dynamics of an enzyme. Moreover, we propose an allosteric role for heparin in the regulation of catB stability in such a manner that the restriction of enzyme flexibility would allow the establishment of stronger contacts and thus the maintenance of overall structure.

Interactions of a Low Molecular Weight Inhibitor from Streptomyces sp. MBR04 with Human Cathepsin D: Implications in Mechanism of Inactivation

Advances in Cathepsin S Inhibition: Challenges and Breakthroughs in Drug Development

Cyanobacterial peptides as a prototype for the design of cathepsin D inhibitors.

Novel selective proline-based peptidomimetics for human cathepsin K inhibition

Design, synthesis, and bioactivities of tasiamide B derivatives as cathepsin D inhibitors.

New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicity

Synthesis and biological evaluation of selective pepstatin based trifluoromethylated inhibitors of Cathepsin D

Inhibitors of Cathepsins K and S Identified Using the DynaMAD Virtual Screening Algorithm

Deciphering Cathepsin K inhibitors: a combined QSAR, docking and MD simulation based machine learning approaches for drug design

Substituted 4H-3,1-benzoxazine-4-one Derivatives as Inhibitors of Cathepsin G

Repurposed pharmacotherapy: targeting cathepsin L with repurposed drugs in virtual screening

Integrated machine learning-based virtual screening and biological evaluation for identification of potential inhibitors against cathepsin K

How does heparin prevent the pH inactivation of cathepsin B? Allosteric mechanism elucidated by docking and molecular dynamics

Cathepsin D as a potential therapeutic target to enhance anticancer drug-induced apoptosis via RNF183-mediated destabilization of Bcl-xL in cancer cells

Cathepsin D inhibitors based on tasiamide B derivatives with cell membrane permeability

Development of Structure-Based Pharmacophore to Target the Β-Catenin-tcf Protein–protein Interaction

Highly Selective Aza-Nitrile Inhibitors for Cathepsin K, Structural Optimization and Molecular Modeling

Design and Synthesis of Novel Cathepsin C Inhibitors with Anti-Inflammatory Activity

Antibody–peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins

Study of a Novel Antiosteoporosis Screening Model Targeted on Cathepsin K.

Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin